Search Results

Calyx / Invicro, a global leader in providing medical imaging solutions and development services to the clinical research community, announces a strategic partnership with BAMF Health, a world leader in molecular imaging and theranostics.

Calyx, a leading technology-enabled provider of Medical Imaging services and IRT/RTSM to drug developers, and Invicro, a next-generation quantitative imaging biomarker company and pre-eminent development partner to pharma sponsors, have agreed to combine their business.

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has advanced a partnership with Invicro LLC.

Invicro LLC, a Konica Minolta company announces that the paper, TauIQ - A canonical image-based algorithm to quantify tau PET scans, will be published in The Journal of Nuclear Medicine (JNM). In conjunction with this publication, Invicro has launched 21 CFR Part 11 compliant TauIQ services in its Core Lab as part of its expanded IQ-Analytics Platform, which includes AmyloidIQ and DaTIQ.

Invicro LLC announces a collaboration with the National Institutes of Health’s new intramural research effort, the Center for Alzheimer’s and Related Dementias, through a data science contract with Data Tecnica International LLC, to offer a curated collection of harmonized brain imaging and genomics data that will help identify dementia and other neurodegenerative disorder risk factors to better stratify subjects and their disease progression.

Invicro LLC, a Konica Minolta Company, announced the expansion of their Software leadership team with the hiring of Mr. Chris Fuller, Vice President of Software and Mr. Timothy Moran as Senior Director of Product Management.

Invicro LLC, a Konica Minolta company, is working with Microsoft to create a free repository of COVID-19 diagnostic CT and X-ray datasets to facilitate understanding and treating this global threat.

Invicro LLC, a Konica Minolta Company and Paige, Inc., the leader in computational pathology, today announced a strategic alliance to provide integrated pathology solutions to support Pharmaceutical and Biotechnology sponsors with their drug discovery and development initiatives

Invicro LLC, a Konica Minolta Company, today announced funding support for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and two of their distinguished scientists within the Alzheimer’s biomarkers space, Drs. Roger Gunn and Kenneth Marek, will join the ADNI-Private Partner Scientific Board (PPSB).

Invicro LLC, a Konica Minolta company announces that the paper “Synaptic Density Marker SV2A is Reduced in Schizophrenia Patients and Unaffected by Antipsychotics in Rats1” has been published in Nature Communications.